FDA commissioner on drug approvals: The problem isn't innovation or speed
There’s “no question” that the US is the top pharma innovator for the world, FDA commissioner Robert Califf said yesterday at the Milken Institute’s Future of Health Summit, but he also pointed to the falling life expectancy in the US, which is now five years shorter than some other high-income countries.
“The problem is not innovation and getting products out quickly. We’re not figuring out how to use them well,” Califf said.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.